Atlas Trials

Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999

Clinical trial NCT02393027 · TERMINATED

Trial details

NCT number
NCT02393027
Sponsor
University Hospital, Tours
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Idiopathic Parkinson Disease
Start date
2015-03-01
Primary completion
2016-11-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.